Portola Valley, California, United States The venture was found in North America in United States. The leading representative office of defined VC is situated in the Portola Valley.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Outlook Therapeutics. Among the most popular fund investment industries, there are Pharmaceutical, Biopharma.
The increased amount of exits for fund were in 2016. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2015.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Longwood Capital Partners, startups are often financed by venBio Partners, Perceptive Advisors, Cormorant Global Healthcare Master Fund. The meaningful sponsors for the fund in investment in the same round are venBio Partners, Perceptive Advisors, Cormorant Global Healthcare Master Fund. In the next rounds fund is usually obtained by venBio Partners, Sabby Management, Perceptive Advisors.
Related Funds
| Fund Name | Location |
| Houshi Equity | China, Lhasa, Tibet |
| Lafayette Plug and Play | France, Ile-de-France, Paris |
| MASA Group | United States, Virginia, Virginia Beach |
| NSW Medical Devices Fund | - |
| Overeasy Ventures | New York, New York, United States |
| Phoenix Satellite Television | China, Hong Kong, New Territories |
| SCP Partners | Pennsylvania, United States, Wayne |
| Seavest Investment Group | New York, United States, White Plains |
| ThirdFrameStudios | - |
| Wipro Ventures | California, Mountain View, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Lassen Therapeutics | $85M | 19 Dec 2023 | San Diego, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Lassen Therapeutics | $85M | 19 Dec 2023 | San Diego, California, United States |
